Arcus Biosciences (RCUS) Change in Cash (2017 - 2026)

Arcus Biosciences' Change in Cash history runs 10 years deep, the most recent figure standing at -$21.0 million for Q1 2026.

• In Q1 2026, Change in Cash fell 150.0% year-over-year to -$21.0 million; the TTM figure through Mar 2026 stood at $9.0 million (up 28.57% YoY), while the FY2025 annual figure was $72.0 million, up 213.04% from the prior year.
• Change in Cash was -$21.0 million for Q1 2026 at Arcus Biosciences, down from -$16.0 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $401.0 million in Q1 2022 to a low of -$276.0 million in Q2 2022.
• Historically, Change in Cash has averaged $3.1 million across 5 years, with a median of -$12.0 million in 2022.
• The sharpest annual moves came in 2023 and 2025: Change in Cash tumbled 375.0% in 2023, then soared 293.1% in 2025.
• A 5-year view of Change in Cash shows it stood at -$12.0 million in 2022, then sank by 375.0% to -$57.0 million in 2023, then climbed by 10.53% to -$51.0 million in 2024, then soared by 68.63% to -$16.0 million in 2025, then sank by 31.25% to -$21.0 million in 2026.
• The last three Change in Cash figures came in at -$21.0 million (Q1 2026), -$16.0 million (Q4 2025), and -$10.0 million (Q3 2025), per Business Quant data.